AMED AMEDISYS INC Capital Structure Changes 8-K Filing 2025 - Debt Restructuring On April 17, 2025, Amedisys Inc. amended its credit agreement, extending the maturity date to July 30, 2027, and including new investment regulations. Their financial results for Q1 2025 will be announced on April 23, 2025, with a credit facility of up to $1 billion including a revolving credit of $550 million.Get access to all SEC 8-K filings of the AMEDISYS INC